Alopecia Areata (AA) (DBCOND0071530)

Identifiers

Synonyms
Areata Alopecia / Alopecia Areata(AA) / Alopecia Areata / Alopecia areata, unspecified / Alopecia areata (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Baricitinib
A Janus kinase inhibitor used to treat moderate to severe rheumatoid arthritis that has responded poorly to at least one TNF antagonist.
Betamethasone
A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.
Betamethasone phosphate
A fast acting ester prodrug of a corticosteroid used to treat inflammatory conditions.
Bupivacaine
A local anesthetic used in a wide variety of superficial and invasive procedures.
Dexamethasone
A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders.
Diphencyprone
Diphencyprone has been used in trials studying the treatment and basic science of Melanoma, Ultraviolet Rays, Immunosuppression, Neoplasm Metastasis, and Hypersensitivity, Delayed, among others.
No drug targets
Methylprednisolone
A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases.
Salicylic acid
An acid used to treat acne, psoriasis, calluses, corns, keratosis pilaris, and warts.
Triamcinolone
A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05723198
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areatatreatment3recruiting
NCT04445363
A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areatatreatment1 / 2active_not_recruiting
NCT02197455
Tofacitnib for the Treatment of Alopecia Areata and Variantstreatment2completed
NCT06060977
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata ParticipantsNo drug interventionstreatment1 / 2active_not_recruiting
NCT04299503
Topical Crisaborole in Patients with Alopecia Areatatreatment2withdrawn
NCT06444451
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areatatreatment2recruiting
NCT06531109
Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibNot AvailableNot Availablerecruiting
NCT06602232
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligotreatment1recruiting
NCT03325296
Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.treatment2terminated
NCT05727306
Healthcare Disparities in Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT06012240
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areatatreatment3recruiting
NCT03899259
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areatatreatment3active_not_recruiting
NCT05866562
Dupilumab in the Treatment of Pediatric Alopecia Areatatreatment2recruiting
NCT06340360
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)treatment2recruiting
NCT04784533
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areatatreatment2completed
NCT05650333
A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Ageother1completed
NCT06279221
Litfulo Capsules Special InvestigationNot AvailableNot Availableactive_not_recruiting
NCT03898479
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areatatreatment2 / 3active_not_recruiting
NCT04006457
Long-Term PF-06651600 for the Treatment of Alopecia Areatatreatment3active_not_recruiting
NCT05398809
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areatatreatment2recruiting
NCT05041803
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults with Alopecia Areatatreatment3completed
NCT05368103
Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areatatreatment2completed
NCT00177021
Aldara for the Treatment of Extensive Alopecia Areatatreatment4completed
NCT03551821
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia AreataNo drug interventionstreatment2completed
NCT06278402
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.treatment3completed
NCT03535233
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areatatreatment4completed
NCT05017454
Sodium Valproate-loaded Nanospanlastics in Patchy Alopecia Areata in Comparison to Topical Steroidstreatment0completed
NCT01802177
Excimer Light for Alopecia AreataNo drug interventionstreatment2unknown_status
NCT01520077
Vytorin in the Treatment of Alopecia Areatatreatment1completed
NCT06088147
Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia AreatatreatmentNot Availablenot_yet_recruiting
NCT04793945
Excimer Light and Topical Steroid in Treatment of Alopecia AreataNo drug interventionstreatment4unknown_status
NCT03630198
Pain Outcomes Following Intralesional Corticosteroid Injectionstreatment4completed
NCT05744505
1565nm Non-ablative Fractional Laser Treat Alopecia AreataNo drug interventionstreatmentNot Availablerecruiting
NCT06018428
Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia AreataNo drug interventionstreatment2active_not_recruiting
NCT06573593
Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE StudyNot AvailableNot Availablerecruiting
NCT01328678
A Study of Vitamin D in Subjects With Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT02604888
Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and FemalesNo drug interventionstreatmentNot Availableunknown_status
NCT01736007
Childhood Alopecia Areata Study Using the 308-nm Excimer LaserNo drug interventionstreatmentNot Availablewithdrawn
NCT05599607
Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia AreataNo drug interventionstreatmentNot Availablecompleted
NCT02561585
LEO 124249 Ointment in the Treatment of Alopecia Areatatreatment2completed
NCT03354637
A Study of ATI-50002 Topical Solution for the Treatment of Alopecia AreataNo drug interventionstreatment2terminated
NCT01797432
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areatatreatment2completed
NCT03651752
DPCP for the Treatment of Alopecia Areatatreatment3recruiting
NCT05098600
The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicNo drug interventionsNot AvailableNot Availablecompleted
NCT03473600
Cryotherapy Versus Steroids In Alopecia Areata:Trichoscopic Evaluationtreatment4unknown_status
NCT05803070
Topical Cetirizine in Treatment of Localized Alopecia AreataNot AvailableNot Availablenot_yet_recruiting
NCT05205070
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areatatreatment2unknown_status
NCT06562270
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness RegistryNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02812342
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variantstreatment2completed
NCT01898806
Intralesional Steroids in the Treatment of Alopecia Areatatreatment4terminated
NCT03570749
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areatatreatment2 / 3active_not_recruiting
NCT01023841
Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Childrentreatment4completed
NCT03847441
Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia AreatatreatmentNot Availablecompleted
NCT02691117
Topical Garlic Concentrate for Alopecia Areata in ChildrenNo drug interventionstreatment3terminated
NCT04034134
Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areatatreatment2completed
NCT04556734
Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areatatreatment2completed
NCT06045624
A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy SubjectsNo drug interventionstreatment1withdrawn
NCT05594316
New Treatment of Alopecia AreatatreatmentNot Availablecompleted
NCT06087796
Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.treatment1not_yet_recruiting
NCT01917058
A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areatatreatment2withdrawn
NCT03078686
Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia AreataNo drug interventionstreatmentNot Availablerecruiting
NCT01385839
Efficacy of Hair Transplantation Compared With Hypodermic Needle Irritation in Alopecia AreataNo drug interventionstreatmentNot Availableterminated
NCT06104839
Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia AreataNo drug interventionstreatment2not_yet_recruiting
NCT02553330
A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)treatment2terminated
NCT04412148
Modified SALT Score for Alopecia Areataother4unknown_status
NCT04011748
Clinical Application of Stem Cell Educator Therapy in Alopecia AreataNo drug interventionstreatment2recruiting
NCT05496426
A Study of KL130008 in Adults With Severe Alopecia AreataNo drug interventionstreatment2not_yet_recruiting
NCT03661866
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISCNo drug interventionsNot AvailableNot Availablerecruiting
NCT05635266
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02312882
Tofacitinib for the Treatment of Alopecia Areata and Its VariantstreatmentNot Availablecompleted
NCT04238091
Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia AreataNo drug interventionstreatment2withdrawn
NCT02599129
A Study of Secukinumab for the Treatment of Alopecia Areatatreatment2terminated
NCT04228029
Comparative Study for Treatment of Alopecia Areata Using Carboxytherapy and Intralesional SteroidsNo drug interventionstreatment4unknown_status
NCT06527729
A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areatatreatment0completed
NCT02548689
PAI-1 Expression in Non-scarring Hair LossNo drug interventionsNot AvailableNot Availableterminated
NCT03759340
ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)treatment2terminated
NCT05861401
Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia AreataNo drug interventionsscreeningNot Availablerecruiting
NCT00999869
The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia AreatatreatmentNot Availableunknown_status
NCT00176969
Response of Topical Capsaicin in Alopecia Areatadiagnostic4completed
NCT01840046
Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areatatreatment1 / 2terminated
NCT06545110
Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinibtreatment1active_not_recruiting
NCT01017510
Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia AreataNo drug interventionsNot AvailableNot Availableunknown_status
NCT05588310
Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated FactorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05589610
Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areatatreatment2completed
NCT03137381
Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areatatreatment2completed
NCT06319781
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or VitiligoNo drug interventionsNot AvailableNot Availablerecruiting
NCT06327581
Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia AreatatreatmentNot Availablerecruiting
NCT06471114
Evaluation of the Efficacy of Systemic Treatments for Alopecia (ESTAA)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02350023
Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areatatreatment4completed
NCT05910138
Evaluation of Serum Levels of Interlukin-15 and Interlukin-21 in Patients With Alopecia AreataNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT04517864
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATAother2terminated
NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT00167102
Alefacept in Patients With Severe Scalp Alopecia AreataotherNot Availablecompleted
NCT01246284
The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia AreatatreatmentNot Availablecompleted
NCT01559584
Phototoxic Doses of Ultraviolet A for Treatment of Alopecia AreatatreatmentNot Availablecompleted
NCT04833179
Fecal Transplant for Alopecia AreataNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00484679
Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areatascreening2completed
NCT03800979
Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areatatreatment4completed
NCT00187577
Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia AreatatreatmentNot Availablecompleted
NCT04147845
Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia AreataNo drug interventionstreatmentNot Availablecompleted
NCT00408798
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum ToxintreatmentNot Availablecompleted
NCT06564805
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia AreataNo drug interventionstreatmentNot Availablerecruiting
NCT02299297
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalistreatment2completed
NCT02684097
A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areatatreatment2completed
NCT06399783
Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areatatreatment4not_yet_recruiting
NCT05051761
Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areatatreatment3active_not_recruiting
NCT05196711
A Study to Evaluate the Safety of MAX-40070 in Healthy SubjectsNo drug interventionstreatment1unknown_status
NCT05551793
Regeneron AA Multicenter (Dupilumab)treatment2recruiting
NCT05485571
Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia AreataNo drug interventionstreatmentNot Availableunknown_status
NCT05391178
Improving Disease SeverityNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT03732807
PF-06651600 for the Treatment of Alopecia Areatatreatment2 / 3completed
NCT05522556
Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Not AvailableNot Availableavailable
NCT03359356
Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)treatment2completed
NCT05255237
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areatatreatment3recruiting
NCT05502952
Combined Microneedling and Topical Pentoxifylline Vesrus Intalesional Pentoxifylline in Treatment of Alopecia Areata: Intra-indiviual Comparative StudytreatmentNot Availableunknown_status
NCT04740970
A Study of JNJ-64304500 in Participants With Alopecia Areatatreatment2withdrawn
NCT02018042
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areatatreatment2completed
NCT04964349
Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia AreataNo drug interventionstreatment0unknown_status
NCT06149936
Excimer Light(308) Therapy for Resistant Alopecia AreataNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05470413
Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areatatreatment3active_not_recruiting
NCT05865041
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participantstreatment2recruiting
NCT05084417
A Prospective, Observational Study of Clinician and Patient-reported Outcomes in Patients With Dermatological ConditionsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04680234
Superficial Cryotherapy Versus Microneedling in Alopecia AreataNo drug interventionstreatmentNot Availablecompleted
NCT06239324
Evaluation of Latanoprost Combined With Fractional Erbium- YAG Lasertreatment1 / 2recruiting
NCT06283316
Systemic Treatments for Alopecia Areata RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04346316
A Phase II Study in Patients With Alopecia Areatatreatment2completed
NCT05278858
Needle-free Delivery of Intralesional Triamcinolone for Pediatric Alopecia Areataother4terminated
NCT03532958
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areatatreatment2withdrawn
NCT01453686
A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areatatreatment3completed
NCT04660786
Intralesional Vitamin D in Alopecia Areatatreatment1 / 2unknown_status
NCT03976622
Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataNot AvailableNot Availableunknown_status
NCT06402630
A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)No drug interventionstreatment2completed
NCT03941548
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areatatreatment2completed
NCT05587257
Role of Minoxidil in Alopecia Areata Transepidermal Drug Delivery of Minoxidil Via Either Fractional Carbon Dioxide Laser or Microneedling Versus Its Topical Nanoparticles Preparation for Treatment of Alopecia AreatatreatmentNot Availablenot_yet_recruiting
NCT05414266
Study Evaluating Efficacy of Topical Squaric Acid Dibutyl Ester in Children and Adolescents With Alopecia AreataNo drug interventionstreatment0recruiting
NCT05556265
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areatatreatment2terminated
NCT02557074
TREg Activation in the Treatment of the PELADE (Alopecia Areata)No drug interventionstreatment3completed
NCT00176982
Plaquenil for Alopecia Areata, Alopecia Totalistreatment4completed
NCT05926882
Efficacy of Oral Apremilast in the Treatment of Alopecia Areata at the Tertiary Care Hospital, Karachi.treatment4completed
NCT05251831
Comparative Study Efficacy and Safety of of Activated Versus Non-Activated PRPNo drug interventionstreatment0completed
NCT05600673
Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areatatreatment1 / 2completed
NCT03240627
Efficacy and Safety of LH-8 in Paediatric Alopecia AreataNo drug interventionstreatment2 / 3completed
NCT00063076
Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areatatreatment2 / 3completed
NCT04003376
Efficacy of Fractional CO2 Laser as a Mono- or Adjuvant Therapy for Alopecia Areatatreatment4unknown_status
NCT02037191
The Efficiency Of The Methotrexate At Patients Affected By Grave Peladetreatment3completed
NCT01950780
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areatatreatment2completed
NCT05745389
CorEvitas Alopecia Areata (AA) Safety and Effectiveness RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01673789
Stem Cell Educator Therapy in Alopecia AreataNo drug interventionstreatment1 / 2unknown_status
NCT00069589
Alopecia Areata RegistryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02636244
Safety and Efficacy Study of SHAPE Gel in Alopecia Areatatreatment2unknown_status
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT05954104
Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich PlasmatreatmentNot Availablecompleted
NCT04246372
Tofacitinib for Immune Skin Conditions in Down Syndrometreatment2active_not_recruiting
NCT02974868
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areatatreatment2completed
NCT05928169
Determinants of Chronic Inflammatory Skin Disease TrajectoriesNo drug interventionsNot AvailableNot Availablerecruiting
NCT06357169
Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial AlopeciasNo drug interventionssupportive_careNot Availableterminated
NCT05885269
Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areatatreatment1completed
NCT03811912
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areatatreatment2completed
NCT04338295
Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needlingNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT04518995
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)treatment3completed
NCT06324695
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEasesNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03873155
The Effectiveness of Mindfulness Based Cognitive Group Therapy for Social Anxiety Symptoms in People Living With Alopecia AreataNo drug interventionstreatmentNot Availablecompleted
NCT04797650
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)treatment3completed
NCT02684123
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia AreatatreatmentNot Availablecompleted
NCT00176943
Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%Not Available4completed